Kong et al. in 2023 reported that AKAP95 is correlated to the activation of the BRAF-MEK-MAPK pathway, acting via phosphorylation of ELK1 and significantly affects immune cell infiltration and colon cancer patient survival [118]. This evidence concerns the gene ELK1 and malignant colon neoplasm.